Participation of African American Persons in Clinical Trials Supporting U.S. Food and Drug Administration Approval of Cancer Drugs

Study of patients enrolled into trials in 2014-18 for cancer drugs that resulted in FDA approval found underrepresentation of African Americans, consistent across cancer subtypes. Authors advocate a focus on recruitment strategies targeting African American participants.


Annals of Internal Medicine